Lactose (India) Ltd | 158 Cr. | 112 | 247/84.3 | 22.8 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.24 Cr. | 2.74 | 4.33/2.71 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 43.8 Cr. | 59.0 | 94.9/44.5 | 14.8 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.7 Cr. | 21.0 | 29.0/13.1 | 31.3 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 69.3 Cr. | 92.1 | 155/79.0 | 11.2 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 39,689 Cr. | 1,406 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Gennex Laboratories Ltd | 304 Cr. | 13.4 | 29.0/11.4 | 16.3 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.53 Cr. | 13.5 | 27.1/9.25 | 131 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 335 Cr. | 710 | 1,024/635 | 17.8 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 99.6 Cr. | 22.8 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 779 Cr. | 265 | 449/145 | 22.1 | 98.6 | 0.47 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.45 Cr. | 26.0 | 36.5/22.8 | 109 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 8.24 Cr. | 3.31 | 12.3/2.11 | 91.6 | 17.9 | 0.00 % | 0.44 % | 0.36 % | 10.0 |
Everest Organics Ltd | 416 Cr. | 429 | 437/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,765 Cr. | 1,325 | 1,584/991 | 64.0 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 121 Cr. | 1.30 | 2.72/1.03 | 25.6 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 55.0 Cr. | 22.9 | 23.8/6.40 | 66.3 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.9 Cr. | 11.8 | 24.6/10.0 | 51.8 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 242 Cr. | 679 | 999/355 | 8.92 | 570 | 0.29 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 31.0 Cr. | 31.0 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 22.0 Cr. | 48.2 | 88.7/36.0 | 45.0 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.10 Cr. | 3.24 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.2 Cr. | 128 | 154/55.1 | 48.0 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 14.6 Cr. | 26.7 | 28.9/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 45.3 Cr. | 60.0 | 124/50.0 | 28.6 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.11 Cr. | 17.0 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,871 Cr. | 742 | 969/347 | 54.8 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 97.2 Cr. | 22.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 10.1 Cr. | 20.0 | 46.0/18.6 | 127 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 156 Cr. | 271 | 418/245 | 16.0 | 110 | 1.66 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 23.9 Cr. | 40.6 | 62.6/14.8 | 68.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 72,774 Cr. | 1,242 | 1,593/994 | 20.5 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 155 Cr. | 249 | 307/156 | 44.6 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 852 Cr. | 170 | 258/148 | 17.0 | 60.5 | 1.47 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 34.6 Cr. | 26.5 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,841 Cr. | 1,202 | 1,322/504 | 62.0 | 160 | 0.12 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.68 Cr. | 0.86 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 281 Cr. | 36.7 | 77.7/34.1 | 19.8 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 7.65 Cr. | 13.1 | 26.0/9.40 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 82.0 Cr. | 3.48 | 6.25/2.82 | 124 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 65,291 Cr. | 30,725 | 31,900/25,260 | 48.9 | 1,657 | 1.33 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,388 Cr. | 705 | 837/486 | 25.6 | 205 | 0.43 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 151 Cr. | 53.2 | 75.8/31.3 | 26.4 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,510 Cr. | 900 | 1,078/440 | | 57.7 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 21,039 Cr. | 1,295 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 794 Cr. | 242 | 325/131 | 42.8 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 410 Cr. | 307 | 428/270 | 14.7 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,115 Cr. | 584 | 950/501 | 48.6 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,684 Cr. | 1,192 | 1,923/991 | 24.6 | 735 | 0.84 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,11,181 Cr. | 3,285 | 3,591/2,513 | 59.7 | 222 | 0.85 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,217 Cr. | 132 | 317/115 | 26.4 | 44.8 | 0.38 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,517 Cr. | 16.1 | 27.9/11.0 | 39.8 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 28,911 Cr. | 1,136 | 1,360/597 | 104 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,676 Cr. | 123 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,38,934 Cr. | 1,829 | 1,960/1,377 | 37.2 | 288 | 0.74 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,783 Cr. | 494 | 886/367 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,122 Cr. | 239 | 398/175 | 33.3 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 410 Cr. | 1,357 | 1,750/626 | 19.5 | 621 | 0.11 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,539 Cr. | 669 | 960/418 | 77.2 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,913 Cr. | 156 | 241/91.8 | 260 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,477 Cr. | 5,866 | 7,600/4,146 | 30.5 | 374 | 1.99 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,452 Cr. | 2,089 | 2,977/1,381 | 29.2 | 321 | 0.77 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 8,331 Cr. | 5,020 | 5,850/4,639 | 33.9 | 368 | 1.59 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 241 Cr. | 68.3 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,474 Cr. | 4,260 | 6,453/3,701 | 31.6 | 820 | 0.82 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 348/81.0 | 8.15 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 3,178 Cr. | 519 | 582/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,170 Cr. | 822 | 1,998/670 | 37.8 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 15,847 Cr. | 12,342 | 18,100/5,540 | 66.0 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 492 Cr. | 21.9 | 56.5/21.0 | 28.9 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,325 Cr. | 856 | 1,639/660 | 8.22 | 399 | 1.11 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,346 Cr. | 61.0 | 101/41.7 | 26.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 10,071 Cr. | 222 | 359/130 | 27.4 | 50.3 | 0.27 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 121 Cr. | 76.3 | 145/70.1 | 11.7 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 399 Cr. | 112 | 177/90.2 | 97.4 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 95,218 Cr. | 2,085 | 2,403/1,493 | 33.2 | 343 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,131 Cr. | 564 | 980/498 | 12.6 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 33,315 Cr. | 618 | 661/385 | 87.6 | 84.6 | 0.19 % | 10.4 % | 8.67 % | 2.00 |
Kwality Pharmaceuticals Ltd | 747 Cr. | 719 | 1,070/481 | 21.2 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 159 Cr. | 74.0 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 916 Cr. | 190 | 370/155 | 19.3 | 103 | 1.58 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 628 Cr. | 391 | 431/271 | 35.1 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,464 Cr. | 908 | 1,310/617 | 43.4 | 373 | 0.55 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 24,441 Cr. | 1,570 | 2,030/1,303 | 38.2 | 207 | 0.78 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,659 Cr. | 250 | 328/109 | 45.5 | 29.7 | 0.80 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 35,219 Cr. | 1,388 | 1,758/1,052 | 48.0 | 264 | 0.29 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,905 Cr. | 64.9 | 108/57.5 | 19.5 | 56.5 | 1.54 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 69.7 Cr. | 12.9 | 34.7/12.2 | 1.08 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 462 Cr. | 76.2 | 186/70.6 | 5.59 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,188 Cr. | 237 | 388/190 | | 118 | 0.63 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,904 Cr. | 398 | 465/267 | 65.8 | 97.6 | 0.30 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,535 Cr. | 1,805 | 3,379/1,243 | 49.7 | 355 | 0.33 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,637 Cr. | 363 | 504/278 | 44.4 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,201 Cr. | 462 | 725/389 | 23.4 | 141 | 0.32 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 39,670 Cr. | 1,406 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 49,032 Cr. | 2,894 | 3,148/1,921 | 57.4 | 98.7 | 1.11 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,364 Cr. | 1,419 | 2,221/1,200 | 20.8 | 557 | 1.41 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,908 Cr. | 424 | 659/359 | 25.2 | 141 | 1.18 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 20,539 Cr. | 1,507 | 1,594/816 | 62.4 | 204 | 0.49 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 97,740 Cr. | 1,171 | 1,421/1,020 | 18.2 | 369 | 0.68 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,027 Cr. | 193 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,24,603 Cr. | 1,543 | 1,702/1,310 | 25.0 | 351 | 0.84 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,499 Cr. | 1,906 | 2,641/1,221 | 28.2 | 334 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 383 Cr. | 134 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,236 Cr. | 117 | 186/92.2 | 14.6 | 95.8 | 0.43 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 70.9 Cr. | 43.9 | 92.0/40.4 | 118 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 40,360 Cr. | 336 | 405/270 | 49.0 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,787 Cr. | 1,770 | 2,215/1,048 | 43.6 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 162 Cr. | 100 | 158/76.3 | 22.4 | 43.2 | 1.20 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 171 Cr. | 76.9 | 113/67.8 | 36.7 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 20,864 Cr. | 8,344 | 9,211/4,800 | 124 | 272 | 0.29 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 2,006 Cr. | 694 | 863/544 | 40.7 | 103 | 0.66 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 222 Cr. | 106 | 145/69.9 | 8.84 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 60,843 Cr. | 5,086 | 6,440/4,407 | 28.1 | 961 | 0.79 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,805 Cr. | 905 | 1,304/725 | 30.0 | 249 | 1.21 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 481 Cr. | 842 | 1,754/763 | 11.9 | 724 | 1.37 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 32,320 Cr. | 2,587 | 3,486/2,022 | 35.1 | 290 | 1.39 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,192 Cr. | 286 | 571/258 | 22.4 | 120 | 1.78 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,271 Cr. | 355 | 635/312 | 24.8 | 126 | 0.28 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 18,566.50 Cr | 1,099.49 | | 43.07 | 183.01 | 0.33% | 15.93% | 16.74% | 6.19 |